Form 4: Astronics CEO Receives New Performance-Based RSU Grant
Insider Transaction Report
Astronics Corp.'s President and CEO, Peter J. Gundermann, was granted 12,150 restricted stock units with vesting tied to future EBITDA performance.
Summary
- Peter J. Gundermann, President/CEO and Director of Astronics Corp. (ATRO), acquired 12,150 Restricted Stock Units (RSUs).
- The transaction date for this acquisition is February 19, 2026.
- Vesting of these RSUs is contingent on Astronics Corp.'s average annual adjusted EBITDA performance for the period from January 1, 2026, to December 31, 2028.
- Between 50% and 150% of the target 12,150 units may vest on February 19, 2029, based on actual performance.
- Gundermann's total beneficial ownership includes 83,906.608 shares of Common Stock and 747,911 shares of Class B Stock directly.
- He also holds various stock options and other RSU grants with different vesting schedules and performance criteria.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. It's a routine compensation disclosure, but the performance-based nature of the RSU grant aligns management incentives with future company profitability, which is generally a positive for shareholders.
Positives
- The grant of performance-based Restricted Stock Units aligns management's incentives with long-term company performance, specifically adjusted EBITDA.
- The CEO's continued accumulation of equity through RSUs demonstrates ongoing commitment to the company's future.
Risks
- Vesting of the RSUs is subject to the company achieving specific average annual adjusted EBITDA targets, meaning the actual number of shares received could be lower than the target if performance metrics are not met.
Future Outlook
The vesting of the newly granted 12,150 Restricted Stock Units is tied to Astronics Corp.'s average annual adjusted EBITDA performance from January 1, 2026, to December 31, 2028, with vesting scheduled for February 19, 2029. This indicates a forward-looking incentive structure for management.
Industry Context
StockSavvy.ai notes that performance-based Restricted Stock Units are a standard component of executive compensation packages in many industries, including aerospace and defense, which Astronics Corp. operates in. Tying vesting to financial metrics like adjusted EBITDA is a common practice to align executive incentives with shareholder value creation.
Comparison to Industry Standards
- The use of adjusted EBITDA as a performance metric for RSU vesting is consistent with common practices in the manufacturing and technology sectors, where operational profitability is a key indicator.
- The vesting range (e.g., 50% to 150% of target) is typical for performance-based equity awards, providing both downside risk and upside potential based on company performance.
- Comparable companies in the aerospace and defense components sector, such as TransDigm Group (TDG) or HEICO Corporation (HEI), often utilize similar long-term incentive structures for their executives, emphasizing metrics like EBITDA, EPS, or total shareholder return.
Stakeholder Impact
- Shareholders: The performance-based nature of the RSU grant aligns the CEO's interests with shareholder value creation through improved EBITDA.
- Employees: No direct impact on general employees is indicated.
Next Steps
- The 12,150 new Restricted Stock Units are scheduled to vest on February 19, 2029, contingent on Astronics Corp.'s average annual adjusted EBITDA performance from January 1, 2026, to December 31, 2028.
- Other existing RSU grants are scheduled to vest on February 23, 2026, February 23, 2027, and February 27, 2028, based on their respective performance periods.
Key Dates
| Date | Description |
|---|---|
| 12/14/2017 | Date exercisable for options with $31.76 exercise price, expiring 12/14/2026. |
| 12/12/2018 | Date exercisable for options with $35.61 exercise price, expiring 12/12/2027. |
| 12/13/2019 | Date exercisable for options with $31.57 exercise price, expiring 12/13/2028. |
| 12/09/2020 | Date exercisable for options with $30.04 exercise price, expiring 12/09/2029. |
| 01/22/2022 | Date exercisable for options with $14.45 exercise price, expiring 01/22/2031. |
| 12/09/2022 | Date exercisable for options with $11.13 exercise price, expiring 12/09/2031. |
| 12/16/2023 | Date exercisable for options with $9.74 exercise price, expiring 12/16/2032. |
| 12/07/2024 | Date exercisable for options with $15.15 exercise price, expiring 12/07/2033. |
| 01/01/2023 | Start of performance period for 9,206 target RSUs. |
| 12/05/2025 | Date exercisable for options with $16.55 exercise price, expiring 12/05/2034. |
| 12/31/2025 | End of performance period for 9,206 target RSUs. |
| 01/01/2024 | Start of performance period for 26,450 target RSUs. |
| 01/01/2025 | Start of performance period for 25,250 target RSUs. |
| 02/19/2026 | Date of acquisition for 12,150 new Restricted Stock Units (RSUs) and start of performance period for these RSUs. |
| 02/23/2026 | Vesting date for 9,206 target RSUs; also the signature date of the filing. |
| 12/04/2026 | Date exercisable for options with $51.72 exercise price, expiring 12/04/2035. |
| 12/31/2026 | End of performance period for 26,450 target RSUs. |
| 02/23/2027 | Vesting date for 26,450 target RSUs. |
| 12/31/2027 | End of performance period for 25,250 target RSUs. |
| 02/27/2028 | Vesting date for 25,250 target RSUs. |
| 12/31/2028 | End of performance period for 12,150 new target RSUs. |
| 02/19/2029 | Vesting date for 12,150 new target RSUs. |
Recommendation
holdThis Form 4 filing reports a routine executive compensation event (an RSU grant) and does not contain information that would fundamentally alter the investment thesis for Astronics Corp. While the performance-based nature of the grant is a positive for aligning management incentives, it's not a catalyst for a "buy" or "sell" recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.
Keywords
Astronics Corp, ATRO, Peter J. Gundermann, SEC Form 4, Restricted Stock Units, RSU, Executive Compensation, Insider Ownership, EBITDA, Performance-Based Equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.